Patent: 8,062,643
✉ Email this page to a colleague
Summary for Patent: 8,062,643
Title: | Use of neurotoxin therapy for treatment of urologic and related disorders |
Abstract: | The present invention related to methods for treating neurological-urological conditions. This is accomplished by administration of at least one neurotoxin. |
Inventor(s): | Schmidt; Richard A (Arvada, CO) |
Assignee: | The Regents of the University of Colorado (Boulder, CO) |
Application Number: | 11/925,938 |
Patent Claims: | see list of patent claims |
Details for Patent 8,062,643
Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Approval Date | Patent No. | Expiredate |
---|---|---|---|---|---|---|---|
Allergan, Inc. | BOTOX COSMETIC | onabotulinumtoxina | For Injection | 103000 | 12/09/1991 | ⤷ Try a Trial | 2017-07-15 |
Allergan, Inc. | BOTOX | onabotulinumtoxina | For Injection | 103000 | 12/09/1991 | ⤷ Try a Trial | 2017-07-15 |
>Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Approval Date | >Patent No. | >Expiredate |
International Patent Family for US Patent 8,062,643
Country | Patent Number | Estimated Expiration |
---|---|---|
Austria | 314085 | ⤷ Try a Trial |
Austria | 320815 | ⤷ Try a Trial |
Austria | 339220 | ⤷ Try a Trial |
Austria | 448792 | ⤷ Try a Trial |
Austria | 552006 | ⤷ Try a Trial |
Australia | 2005234633 | ⤷ Try a Trial |
>Country | >Patent Number | >Estimated Expiration |